MEI Pharma, Inc. (MEIP) financial statements (2021 and earlier)

Company profile

Business Address 3611 VALLEY CENTER DRIVE
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1047410354466449
Cash and cash equivalents910138111914
Short-term investments95658945354535
Contract with customer, asset01
Other undisclosed current assets2722110
Total current assets:1068210455476449
Noncurrent Assets
Property, plant and equipment0000000
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Total noncurrent assets:1000001
TOTAL ASSETS:1078310556476550
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7974665
Accounts payable3541112
Accrued liabilities4533443
Employee-related liabilities     11
Deferred revenue3
Deferred revenue and credits11   
Other undisclosed current liabilities 5   (1)(1)
Total current liabilities:101485655
Noncurrent Liabilities
Liabilities, other than long-term debt3      
Deferred revenue3
Other undisclosed noncurrent liabilities172046    
Total noncurrent liabilities:202046    
Total liabilities:3035545655
Stockholders' equity
Stockholders' equity attributable to parent, including:77485051426045
Common stock, share subscribed but unissued, subscriptions receivable (5)     
Additional paid in capital332279265225219216169
Accumulated deficit(254)(231)(214)(174)(177)(156)(123)
Other undisclosed stockholders' equity attributable to parent 5     
Total stockholders' equity:77485051426045
TOTAL LIABILITIES AND EQUITY:1078310556476550

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues55223   
Revenue, net223   
Cost of revenue
(Cost of Goods and Services Sold)
(4)(4)(3)(5)   
Gross profit:11(2)18   
Operating expenses(50)(47)(27)(16)(21)(33)(27)
Operating income (loss):(49)(46)(29)2(21)(33)(27)
Nonoperating income2210000
Investment income, nonoperating2210000
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes2828(12)(0)(0)(0) 
Income (loss) from continuing operations before income taxes:(20)(17)(40)3(21)(33)(27)
Income tax expense (0)(0)(0)(0)(0)(0)
Income (loss) before gain (loss) on sale of properties:(20)(17)(40)3(21)(33)(27)
Other undisclosed net income (loss)(4)00    
Net income (loss):(24)(17)(40)3(21)(33)(27)
Other undisclosed net income (loss) attributable to parent(14)  000 
Net income (loss) available to common stockholders, basic:(38)(17)(40)3(21)(33)(27)
Other undisclosed net loss available to common stockholders, diluted(14)(38)     
Net income (loss) available to common stockholders, diluted:(52)(55)(40)3(21)(33)(27)

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):(24)(17)(40)3(21)(33)(27)
Comprehensive income (loss), net of tax, attributable to parent:(24)(17)(40)3(21)(33)(27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: